Aviva’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120,275
| Closed | -$5.21M | – | 891 |
|
|
2025
Q1 | $5.21M | Buy |
120,275
+16,624
| +16% | +$720K | 0.01% | 533 |
|
|
2024
Q4 | $5.82M | Buy |
+103,651
| New | +$5.82M | 0.02% | 516 |
|
|
2024
Q3 | – | Sell |
-13,684
| Closed | -$578K | – | 906 |
|
|
2024
Q2 | $578K | Buy |
13,684
+6,844
| +100% | +$289K | ﹤0.01% | 811 |
|
|
2024
Q1 | $472K | Sell |
6,840
-30,080
| -81% | -$2.08M | ﹤0.01% | 871 |
|
|
2023
Q4 | $2.73M | Sell |
36,920
-70,134
| -66% | -$5.19M | 0.01% | 565 |
|
|
2023
Q3 | $7.3M | Buy |
107,054
+84,888
| +383% | +$5.79M | 0.03% | 464 |
|
|
2023
Q2 | $2.08M | Buy |
22,166
+2,168
| +11% | +$204K | 0.01% | 618 |
|
|
2023
Q1 | $1.36M | Sell |
19,998
-4,020
| -17% | -$273K | 0.01% | 817 |
|
|
2022
Q4 | $1.19M | Sell |
24,018
-247
| -1% | -$12.2K | 0.01% | 769 |
|
|
2022
Q3 | $788K | Sell |
24,265
-30,033
| -55% | -$975K | ﹤0.01% | 927 |
|
|
2022
Q2 | $2.14M | Sell |
54,298
-1,432
| -3% | -$56.4K | 0.01% | 766 |
|
|
2022
Q1 | $3.9M | Buy |
55,730
+668
| +1% | +$46.7K | 0.02% | 642 |
|
|
2021
Q4 | $4.29M | Buy |
55,062
+2,763
| +5% | +$215K | 0.02% | 629 |
|
|
2021
Q3 | $4.99M | Sell |
52,299
-2,646
| -5% | -$253K | 0.02% | 579 |
|
|
2021
Q2 | $6.83M | Buy |
54,945
+5,668
| +12% | +$705K | 0.03% | 498 |
|
|
2021
Q1 | $6.49M | Buy |
49,277
+40
| +0.1% | +$5.27K | 0.03% | 455 |
|
|
2020
Q4 | $6.52M | Buy |
49,237
+1,167
| +2% | +$155K | 0.03% | 426 |
|
|
2020
Q3 | $4.9M | Sell |
48,070
-1,136
| -2% | -$116K | 0.03% | 456 |
|
|
2020
Q2 | $4.28M | Sell |
49,206
-37
| -0.1% | -$3.22K | 0.03% | 459 |
|
|
2020
Q1 | $2.86M | Buy |
49,243
+415
| +0.8% | +$24.1K | 0.02% | 665 |
|
|
2019
Q4 | $4.52M | Buy |
48,828
+5,367
| +12% | +$496K | 0.03% | 494 |
|
|
2019
Q3 | $3.93M | Buy |
+43,461
| New | +$3.93M | 0.03% | 490 |
|